Company profile
Marpai, Inc.
OTC: MRAI · Healthcare · Medical - Healthcare Plans
#563 of 1,418 Healthcare companies by revenuebottom-quartile growth
EA Score
34DFH 31DQ 34GM 35SS 46
v0.1 · 65/100 weight · provisional
↑ workforce scale, market scale · ↓ listing tenure, balance-sheet leverage
Methodology →Revenue TTM
$16.6M
Rev growth YoY (TTM)
-29.7%
Net income (FY)
-$16.6M
Employees
107
as of 2026-08-22
Market cap
$58.9M
as of 2026-08-22
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$18.1M$18.1M2025
Net income-$16.6M-$16.6M2025
Operating income-$13.6M-$13.6M2025
Total assets$10.9M$10.9M2025
Liabilities$43.5M$43.5M2025
Equity-$32.6M-$32.6M2025
Revenue trend
FY2021 – FY2025 · USD
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Marpai, Inc.’s revenue?
Marpai, Inc. booked $18.1M in FY2025 revenue, contracting 36% year over year — slower than 77% of Healthcare companies we track, at a -91.5% net margin.
Peers · Healthcare
PD-Rx Pharmaceuticals, Inc.70BAvicanna Inc.55CTrees Corporation——Response Genetics, Inc——ManifestSeven Holdings Corporation——Vibe Growth Corporation58CNeighbors
New York →Key facts
CEODamien Francis Lamendola
SectorHealthcare
IndustryMedical - Healthcare Plans
HeadquartersNew York City, NY
ExchangeOTC: MRAI
Employees107
IPO date2021-10-27
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.